Sofia 2 SARS Antigen+ FIA, Sofia 2 SARS Antigen+ FIA Control Swab Set
Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings. De Novo DEN220039, from Quidel Corporation (San Diego, CA). Product code QVF, class 2.
As of Nov 19, 2026, DEN220039 is an FDA De Novo held by Quidel Corporation, granted on Mar 8, 2023 after 265 days, with no recalls tied to it in FDA's recall database.
- Review time: 265 days
- Recalls: 0
- Cited as a predicate by: 5 devices
- Design
- Prospective, multi-center, consecutive-enrollment study of symptomatic subjects vs. EUA RT-PCR comparator
- Enrolled
- 581
- Where
- 6 sites
- Primary endpoint
- Clinical sensitivity (PPA) and specificity (NPA) vs. RT-PCR comparator
- Result
- PPA 89.0% (97/109; 95% CI 81.7%-93.6%); NPA 99.6% (470/472; 95% CI 98.5%-99.9%)
- Sofia 2 SARS Antigen+ FIA; Sofia 2 Lyme FIAK254264 · Ortho-Clinical Diagnostics, Inc. (QuidelOrtho) · Sep 4, 2026
- Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab SetK233688 · Quidel Corporation · Dec 13, 2023
- Healgen Rapid COVID-19 Antigen TestK232377 · Healgen Scientific,, LLC · Apr 19, 2024
- Nano-Check™ COVID-19 Antigen TestK231187 · Nano-Ditech Corporation · Jan 23, 2024
- Id Now Covid-19 2.0K221925 · Abbott Diagnostics Scarborough, Inc. · Aug 10, 2023
- Healgen Rapid COVID-19 Antigen TestK232377 · Healgen Scientific,, LLC · Apr 19, 2024
- Nano-Check™ COVID-19 Antigen TestK231187 · Nano-Ditech Corporation · Jan 23, 2024
- Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab SetK233688 · Quidel Corporation · Dec 13, 2023
- Document
- De Novo decision summary (PDF) ↗
- Type
- Post-NSE
- Received
- Jun 16, 2022
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3982
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files